BenzingaBenzinga Japan
BenzingaBenzinga Japan
BenzingaBenzinga Japan
木曜日, 9 24

Artelo Biosciences Inc

ARTLNASDAQ
Trade with Public
Trade with Public
$4.84
-2.47-33.79%
最終更新: Sep 24, 10:14 AM
PRO
なぜ動いているのか？:Artelo Biosciences shares are trading higher after the company announced th...
概要ニュース業績予想イベント目標株価財務センチメント株主構成比較株式レポート

Artelo Biosciences Earnings & Forecasts

Artelo Biosciences (ARTL) earnings history, EPS estimates, revenue forecasts and company guidance.

Earnings Per Share (Non-GAAP)

Quarterly Revenue (Billions)

Artelo Biosciences Guidance

Recent Earnings Results

MetricQ2 '26Q1 '26Q4 '25Q3 '25
Earnings Per Share (Non-GAAP)
Estimate—$-14.13$-42.39$-22.14
Actual$-8.01$-36.00$37.26$-107.19
Surprise—-154.8%+187.9%-384.1%
Revenue
Estimate————
Actual$0$0—$0
Surprise————

Earnings & Guidance News

PRO
Artelo Biosciences Q2 EPS $(0.89) Up From $(16.83) YoY

Artelo Biosciences (NASDAQ:ARTL) reported quarterly losses of $(0.89) per share. This is a 94.71 percent increase over losses of $(16.83) per share from the same period last year.
Benzinga Newsdesk

PRO
Artelo Biosciences Q1 EPS $(4.00) Misses $(1.57) Estimate

Artelo Biosciences (NASDAQ:ARTL) reported quarterly losses of $(4.00) per share which missed the analyst consensus estimate of $(1.57) by 154.78 percent. This is a 69.14 percent increase over losses of $(12.96) per share
Benzinga Newsdesk

PRO
Artelo Biosciences Q4 EPS $1.38 Beats $(1.57) Estimate

Artelo Biosciences (NASDAQ:ARTL) reported quarterly earnings of $1.38 per share which beat the analyst consensus estimate of $(1.57) by 187.9 percent. This is a 119.66 percent increase over losses of $(7.02) per share
Benzinga Newsdesk

PRO
Artelo Biosciences Q3 EPS $(3.97) Misses $(0.82) Estimate

Artelo Biosciences (NASDAQ:ARTL) reported quarterly losses of $(3.97) per share which missed the analyst consensus estimate of $(0.82) by 384.15 percent. This is a 89.05 percent decrease over losses of $(2.10) per share
Benzinga Newsdesk

Nasdaq Gains Over 100 Points; Science Applications Shares Fall After Q2 Results

Avi Kapoor

PRO
Artelo Biosciences Q2 EPS $(5.61) Misses $(4.19) Estimate

Artelo Biosciences (NASDAQ:ARTL) reported quarterly losses of $(5.61) per share which missed the analyst consensus estimate of $(4.19) by 33.89 percent. This is a 24.67 percent decrease over losses of $(4.50) per share
Benzinga Newsdesk

データとAPI: Benzinga API · 株式ニュースAPI · アナリスト評価API · 企業ロゴAPI

BenzingaBenzinga Japan

ニュース

パートナーシップ

ベンジンガ・グローバル

© 2026 Benzinga | All Rights Reserved